Although Mounjaro and Zepbound are FDA-accredited for form two diabetes and weight problems, these medicines — in addition to Novo Nordisk’s Ozempic and Wegovy — have acquired recognition all over the previous 12 months as numerous have made use of them off-label for weight loss.